Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

NCT02996916 is registered in ClinicalTrials.gov with Kurume University as lead sponsor.

NCT NCT02996916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue
Lead sponsor
Kurume University
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2015
Completion date
December 31, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy of olmesartan on cerebral glucose metabolism in essential hypertension